Ischemia-Modified Albumin and Antioxidant Protection in Newborns with Asphyxia of Varying Severity.

antioxidant capacity of blood serum ischemia-modified albumin newborns with asphyxia oxidative stress serum albumin

Journal

Bulletin of experimental biology and medicine
ISSN: 1573-8221
Titre abrégé: Bull Exp Biol Med
Pays: United States
ID NLM: 0372557

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 21 02 2023
medline: 2 11 2023
pubmed: 19 10 2023
entrez: 19 10 2023
Statut: ppublish

Résumé

The content of ischemia-modified albumin (IMA), serum albumin, and antioxidant capacity of blood serum was studied in healthy newborns and in newborns with moderate and severe asphyxia on days 1-2 and 3-4 of the postnatal period. Changes in these indicators were found in both groups of newborns with birth asphyxia in comparison with the group of healthy newborns and were more pronounced in children with severe asphyxia. An increase in the IMA level (by 1.6 times; p<0.001) and antioxidant capacity of blood serum (by 2.4 times; p<0.001) and a decrease in serum albumin content (by 1.5 times; p<0.001) were found in severe asphyxia on days 1-2. Analysis of changes in these indicators by days 3-4 allows to talk about a decrease in the intensity of free-radical reactions in newborns with birth asphyxia during complex therapy.

Identifiants

pubmed: 37855865
doi: 10.1007/s10517-023-05913-z
pii: 10.1007/s10517-023-05913-z
doi:

Substances chimiques

ischemia-modified albumin 0
Serum Albumin 0
Biomarkers 0
Antioxidants 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

620-624

Informations de copyright

© 2023. Springer Science+Business Media, LLC, part of Springer Nature.

Références

Dursun A, Okumus N, Zenciroglu A. Ischemia-modified albumin (IMA): could it be useful to predict perinatal asphyxia? J. Matern. Fetal. Neonatal. Med. 2012;25(11):2401-2405. doi: https://doi.org/10.3109/14767058.2012.697943
doi: 10.3109/14767058.2012.697943 pubmed: 22642562
Martini S, Castellini L, Parladori R, Paoletti V, Aceti A, Corvaglia L. Free Radicals and Neonatal Brain Injury: From Underlying Pathophysiology to Antioxidant Treatment Perspectives. Antioxidants (Basel). 2021;10(12):2012. doi: https://doi.org/10.3390/antiox10122012
doi: 10.3390/antiox10122012 pubmed: 34943115 pmcid: 8698308
Martini S, Austin T, Aceti A, Faldella G, Corvaglia L. Free radicals and neonatal encephalopathy: mechanisms of injury, biomarkers, and antioxidant treatment perspectives. Pediatr. Res. 2020;87(5):823-833. doi: https://doi.org/10.1038/s41390-019-0639-6
doi: 10.1038/s41390-019-0639-6 pubmed: 31655487
Torres-Cuevas I, Parra-Llorca A, Sánchez-Illana A, Nuñez-Ramiro A, Kuligowski J, Cháfer-Pericás C, Cernada M, Escobar J, Vento M. Oxygen and oxidative stress in the perinatal period. Redox Biol. 2017;12:674-681. doi: https://doi.org/10.1016/j.redox.2017.03.011
doi: 10.1016/j.redox.2017.03.011 pubmed: 28395175 pmcid: 5388914
Kumral A, Okyay E, Guclu S, Gencpinar P, Islekel GH, Oguz SS, Kant M, Demirel G, Duman N, Ozkan H. Cord blood ischemia-modified albumin: is it associated with abnormal Doppler findings in complicated pregnancies and predictive of perinatal asphyxia? J. Obstet. Gynaecol. Res. 2013;39(3):663-671. doi: https://doi.org/10.1111/j.1447-0756.2012.02055.x
doi: 10.1111/j.1447-0756.2012.02055.x pubmed: 23278910
Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J. Emerg. Med. 2000;19(4):311-315. doi: https://doi.org/10.1016/s0736-4679(00)00255-9
doi: 10.1016/s0736-4679(00)00255-9 pubmed: 11074321
Teselkin YuO, Babenkova IV, Osipov AN. A Modified Chemiluminescent Method for Determination of the Antioxidant Capacity of Biological Fluids and Tissues. Biophysics. 2019;64(5):708-716. doi: https://doi.org/10.1134/S0006350919050233
Perrone S, Szabó M, Bellieni CV, Longini M, Bangó M, Kelen D, Treszl A, Negro S, Tataranno ML, Buonocore G. Whole body hypothermia and oxidative stress in babies with hypoxic-ischemic brain injury. Pediatr. Neurol. 2010;43(4):236-240. doi: https://doi.org/10.1016/j.pediatrneurol.2010.05.009
doi: 10.1016/j.pediatrneurol.2010.05.009 pubmed: 20837300
Mondal N, Bhat BV, Banupriya C, Koner BC. Oxidative stress in perinatal asphyxia in relation to outcome. Indian J. Pediatr. 2010;77(5):515-517. doi: https://doi.org/10.1007/s12098-010-0059-4
doi: 10.1007/s12098-010-0059-4 pubmed: 20401708
Brucknerová I, Benedeková M, Pechán I, Holomán K, Bieliková E, Kostrová A, Ujházy E, Dubovický M, Mach M. Delivery as a “physiological stress” and its influence on some parameters of oxidative stress. Neuro Endocrinol. Lett. 2006;27(Suppl. 2):65-68.
pubmed: 17159782
Beken S, Aydın B, Dilli D, Erol S, Zenciroğlu A, Okumuş N. Can biochemical markers predict the severity of hypoxic-ischemic encephalopathy? Turk. J. Pediatr. 2014;56(1):62-68.
pubmed: 24827949
Belinskaia DA, Voronina PA, Goncharov NV. Integrative Role of Albumin: Evolutionary, Biochemical and Pathophysiological Aspects. J. Evol. Biochem. Physiol. 2021;57(6):1419-1448. doi: https://doi.org/10.1134/S002209302106020X
doi: 10.1134/S002209302106020X pubmed: 34955553 pmcid: 8685822
Bal W, Sokołowska M, Kurowska E, Faller P. Binding of transition metal ions to albumin: sites, affinities and rates. Biochim. Biophys. Acta. 2013;1830(12):5444-5455. doi: https://doi.org/10.1016/j.bbagen.2013.06.018
doi: 10.1016/j.bbagen.2013.06.018 pubmed: 23811338
Ozsurekci Y, Aykac K. Oxidative Stress Related Diseases in Newborns. Oxid. Med. Cell. Longev. 2016;2016:2768365. doi: https://doi.org/10.1155/2016/2768365
doi: 10.1155/2016/2768365 pubmed: 27403229 pmcid: 4926016
Elsadek AE, FathyBarseem N, Suliman HA, Elshorbagy HH, Kamal NM, Talaat IM, Al-Shokary AH, Abdel Maksoud YH, Ibrahim AO, Attia AM, Abdelhalim WA, Abdelghani WE. Hepatic Injury in Neonates with Perinatal Asphyxia. Glob. Pediatr. Health. 2021;8:2333794X20987781. doi: https://doi.org/10.1177/2333794X20987781

Auteurs

S F Delsuz (SF)

Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.

R I Shalina (RI)

Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.

E Ya Karaganova (EY)

Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.

M A Kurtser (MA)

Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.

I V Babenkova (IV)

Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.

Yu O Teselkin (YO)

Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia. teselkin-box@mail.ru.

A N Osipov (AN)

Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.

Yu A Vladimirov (YA)

Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH